Centro de Investigación en Red en Enfermedades Cardiovasculares-ko ikertzaileekin lankidetzan egindako argitalpenak (5)

2022

  1. Left atrial enlargement in competitive athletes and atrial electrophysiology

    Revista Espanola de Cardiologia, Vol. 75, Núm. 5, pp. 421-428

2021

  1. Sustained elevated blood pressure accelerates atherosclerosis development in a preclinical model of disease

    International Journal of Molecular Sciences, Vol. 22, Núm. 16

2020

  1. The pharmaceutical solvent N-methyl-2-pyrollidone (NMP) attenuates inflammation through Krüppel-like factor 2 activation to reduce atherogenesis

    Scientific Reports, Vol. 10, Núm. 1

2018

  1. Mirabegron, a Clinically Approved β3 Adrenergic Receptor Agonist, Does Not Reduce Infarct Size in a Swine Model of Reperfused Myocardial Infarction

    Journal of Cardiovascular Translational Research, Vol. 11, Núm. 4, pp. 310-318

2017

  1. Neutrophil stunning by metoprolol reduces infarct size

    Nature Communications, Vol. 8